ZORBAX 300SB-CN 5um, 4.6 x 50mm
Order number: 860950-905
Part number: AC100073666
Get Quote
Price Breakdown
Formulated to support synthetic operations, the Zorbax 300Sb-Cn 5Um, 4.6 X 50Mm column offers a reversed phase separation mode suitable for biopharmaceutical applications such as peptides, proteins, and monoclonal antibodies (mABs). This high-performance liquid chromatography (HPLC) column features fully porous ZORBAX particles and a 300 A pore size, ensuring optimal performance within a pH range of 1-8. The column is constructed from stainless steel and can withstand pressures up to 400 bar, while maintaining a particle size of 5 um. The ZORBAX StableBond technology guarantees stability at low pH levels, making this column an ideal choice for robust synthetic operations.
- Category: ZORBAX StableBond
- Pore Size: 300 A
- Shipping Solvent: Acetonitrile/Water
- LC Column Phase: 300SB-CN
- Separation Mode: Reversed Phase
- LC Platform: Stainless Steel
- UNSPSC 13.5: 41115709
- Hardware: SS
- pH Range: 1-8
- LC Column Brand: ZORBAX
- Inner Diameter (ID): 4.6 mm
- Particle Type: Fully Porous
- Part Number Application: Peptides, Proteins, Monoclonal Antibodies (mABs)
- Technique: LC, LC & LC/MS
- LC Column Maximum Temperature: 80 C
- Length: 50 mm
- Pressure Rating: 400 bar
- Particle Size: 5 um
- Part Number Application Domain: Biopharma
| Name | Value | |
|---|---|---|
| Length | : | 50 mm |
| Hardware | : | SS |
| pH Range | : | 1-8 |
| Pore Size | : | 300 A |
| Technique | : | LC, LC & LC/MS |
| LC Platform | : | Stainless Steel |
| UNSPSC 13.5 | : | 41115709 |
| Particle Size | : | 5 um |
| Particle Type | : | Fully Porous |
| LC Column Brand | : | ZORBAX |
| LC Column Phase | : | 300SB-CN |
| Pressure Rating | : | 400 bar |
| Separation Mode | : | Reversed Phase |
| Shipping Solvent | : | Acetonitrile/Water |
| Inner Diameter (ID) | : | 4.6 mm |
| Part Number Application | : | Peptides, Proteins, Monoclonal Antibodies (mABs) |
| LC Column Maximum Temperature | : | 80 C |
| Part Number Application Domain | : | Biopharma |
